Work

Molnupiravir; an effective drug in treating COVID-19?

Year: 2021

Type: article

Abstract: Developing effective antiviral drugs to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to be a challenge since its outbreak two years ago.Molnupiravir could be a potential therapeutic candidate to treat infected patients with SARS-CoV-2.However, there have been concerns about the possibility of molnupiravir-induced carcinogenesis and birth defects.

Source: Journal of Preventive Epidemiology

DOI: 10.34172/jpe.2022.11

Authors: Alireza Pouramini, Fatemeh Kafi, Shakiba Hassanzadeh, Sanam Saeifar, Hamid Reza Jahantigh

Institutions: Nickan Research Institute, Goethe University Frankfurt, University of Bari Aldo Moro

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3214348830